KWALITY PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of KWALITY PHARMACEUTICALS have increased by 20.52% YoY .
The Earnings Per Share (EPS) of KWALITY PHARMACEUTICALS has increased by 69.01 % YoY. |
||
KWALITY PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 539997|NSE : KPL]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹370 Cr | ₹307 Cr | ₹251 Cr | ₹456 Cr | ₹262 Cr |
| Expenses | ₹290 Cr | ₹241 Cr | ₹190 Cr | ₹285 Cr | ₹233 Cr |
| Operating Profit (Excl OI) | ₹80 Cr | ₹66 Cr | ₹61 Cr | ₹172 Cr | ₹29 Cr |
| Other Income | ₹1.92 Cr | ₹1.83 Cr | ₹2.94 Cr | ₹3.51 Cr | ₹1.59 Cr |
| Interest | ₹9.88 Cr | ₹10 Cr | ₹6.61 Cr | ₹2.92 Cr | ₹2.68 Cr |
| Depreciation | ₹18 Cr | ₹20 Cr | ₹15 Cr | ₹11 Cr | ₹6.49 Cr |
| Profit Before Tax | ₹54 Cr | ₹31 Cr | ₹26 Cr | ₹162 Cr | ₹21 Cr |
| Profit After Tax | ₹40 Cr | ₹24 Cr | ₹19 Cr | ₹120 Cr | ₹15 Cr |
| Consolidated Net Profit | ₹40 Cr | ₹24 Cr | ₹19 Cr | ₹120 Cr | ₹15 Cr |
| Earnings Per Share (Rs) | ₹64.90 | ₹38.40 | ₹22.93 | ₹18.67 | ₹115.64 |
| PAT Margin (%) | 13.39 | 10.75 | 7.69 | 7.68 | 26.29 |
| ROE(%) | 22.67 | 16.36 | 11.16 | 10.15 | 99.66 |
| ROCE(%) | 24.01 | 18.36 | 13.57 | 12.27 | 97.93 |
| Total Debt/Equity(x) | 0.39 | 0.43 | 0.44 | 0.45 | 0.30 |
Key Financials |
||
| Market Cap | : | ₹ 3,582.5 Cr |
| Revenue (TTM) | : | ₹ 554.0 Cr |
| Net Profit(TTM) | : | ₹ 81.0 Cr |
| EPS (TTM) | : | ₹ 77.9 |
| P/E (TTM) | : | 44.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| KWALITY PHARMACEUTICALS | 10% | 22.5% | 203.1% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.4% | -1.3% | 21.5% |
| DIVIS LABORATORIES | 2.7% | 16.1% | 38.6% |
| TORRENT PHARMACEUTICALS | -1.5% | -3.3% | 35.6% |
| CIPLA | -0.7% | 1.4% | -2% |
| DR REDDYS LABORATORIES | 3.9% | -1.8% | 0.4% |
| MANKIND PHARMA | -0.7% | -4.9% | -4.9% |
| LUPIN | -1.8% | -10.6% | 16.2% |
| ZYDUS LIFESCIENCES | 1.7% | -1.2% | 24.1% |
KWALITY PHARMACEUTICALS Revenues
[BOM: 539997|NSE : KPL]
| Y-o-Y | 20.52 % |
| 5 Yr CAGR | 9.03 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹370 Cr | 20.52 | |
| Mar2025 | ₹307 Cr | 22.36 | |
| Mar2024 | ₹251 Cr | -44.97 | |
| Mar2023 | ₹456 Cr | 74.11 | |
| Mar2022 | ₹262 Cr | - | |
KWALITY PHARMACEUTICALS Operating Profit
[BOM: 539997|NSE : KPL]
| Y-o-Y | 21.22 % |
| 5 Yr CAGR | 29.20 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹80 Cr | 21.22 | |
| Mar2025 | ₹66 Cr | 9.20 | |
| Mar2024 | ₹61 Cr | -64.62 | |
| Mar2023 | ₹172 Cr | 494.98 | |
| Mar2022 | ₹29 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 0.56 % |
| 5 Yr CAGR | 18.50 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 21.71% | 0.56 | |
| Mar2025 | 21.59% | -10.75 | |
| Mar2024 | 24.19% | -35.72 | |
| Mar2023 | 37.63% | 241.78 | |
| Mar2022 | 11.01% | - | |
KWALITY PHARMACEUTICALS Profit After Tax
[BOM: 539997|NSE : KPL]
| Y-o-Y | 67.44 % |
| 5 Yr CAGR | 27.36 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹40 Cr | 67.44 | |
| Mar2025 | ₹24 Cr | 22.83 | |
| Mar2024 | ₹19 Cr | -83.85 | |
| Mar2023 | ₹120 Cr | 692.23 | |
| Mar2022 | ₹15 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 24.56 % |
| 5 Yr CAGR | -15.52 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 13.39 % | 24.56 | |
| Mar2025 | 10.75 % | 39.79 | |
| Mar2024 | 7.69 % | 0.13 | |
| Mar2023 | 7.68 % | -70.79 | |
| Mar2022 | 26.29 % | - | |
KWALITY PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 539997|NSE : KPL]
| Y-o-Y | 69.01 % |
| 5 Yr CAGR | -13.45 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹65 | 69.01 | |
| Mar2025 | ₹38 | 67.47 | |
| Mar2024 | ₹23 | 22.82 | |
| Mar2023 | ₹19 | -83.86 | |
| Mar2022 | ₹116 | - | |
KWALITY PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 539997|NSE : KPL]
| Y-o-Y | 30.77 % |
| 5 Yr CAGR | -29.63 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 24.01% | 30.77 | |
| Mar2025 | 18.36% | 35.30 | |
| Mar2024 | 13.57% | 10.59 | |
| Mar2023 | 12.27% | -87.47 | |
| Mar2022 | 97.93% | - | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹3,444.8 |
| Current MarketCap | : | ₹ 3,582.5 Cr |
| Updated EOD on | : | Aug 14,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 10% |
22.5% |
203.1% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
KWALITY PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | -0.5% | 1% | 17.4% |
No NSE index found
You may also like the below Video Courses
FAQ about KWALITY PHARMACEUTICALS Financials
How the annual revenues of KWALITY PHARMACEUTICALS have changed ?
The Revenues of KWALITY PHARMACEUTICALS have increased by 20.52% YoY .
How the Earnings per Share (EPS) of KWALITY PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of KWALITY PHARMACEUTICALS has increased by 69.01 % YoY .
Check out Intrinsic Value of Peers of KWALITY PHARMACEUTICALS
Compare Stock Analytics of Peers of KWALITY PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
